Thursday, July 9, 2026

pharma · Advanced Or Metastatic Merkel Cell Carcinoma · Cutaneous Melanoma, Stage III · HURA

TuHURA Biosciences, Inc./NV

TuHURA Biosciences, Inc./NV trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Tampa, USA HQ
1996 Founded
32 Employees
Public company Type
HURA · NYSE Ticker
Company details
Status
Public
HQ
Tampa, USA
Founded
1996
Employees
32
Programs
4
Drugs
0
Patents
0
Intelligence · Clinical Trials

TuHURA Biosciences, Inc./NV clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to TuHURA Biosciences, Inc./NV programs — each row shows trial ID, program name, phase, status, and indication.

TuHURA Biosciences, Inc./NV trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for TuHURA Biosciences, Inc./NV.

  1. IFx-Hu2.0 — Phase 3

    Clinical update
  2. IFx-Hu2.0 — Phase 1

    Clinical update
  3. IFx-Hu2.0 — Phase 1

    Clinical update
  4. IFx-Hu2.0 — Phase 1

    Clinical update

Trial registry

5 studies